Observation on tissue factor pathway and some other coagulation parameters during the onset of acute cerebrocardiac

Meixia He1, Zhibin Wen, Xiaofan He

  • 1Department of Physiology, Xiangya Hospital, Xiangya Medical College, Central South University, Changsha Hunan 410078, China.

Thrombosis Research
|December 14, 2002
PubMed

Insights

Thrombosis drives acute myocardial infarction (AMI) and acute ischemic stroke (AIS). This study links coagulation factors like tissue factor (TF) to these events, revealing distinct patterns in AMI versus AIS.

Area of Science:

  • Cardiovascular Medicine
  • Hematology
  • Thrombosis Research

Background:

  • Thrombosis is central to acute myocardial infarction (AMI) and acute ischemic stroke (AIS).
  • The precise role of coagulation factors in arterial diseases remains unclear.
  • Understanding these factors is crucial for managing thrombotic events.

Purpose of the Study:

  • To investigate the relationship between coagulation factors, anticoagulants, and the occurrence of AMI and AIS.
  • To differentiate the coagulation profiles in patients with AMI and AIS compared to healthy individuals.

Main Methods:

  • Comparative analysis of coagulation factors and inhibitors in 69 AMI patients, 71 AIS patients, and 50 healthy controls.
  • Measurement of plasma activities and antigens for tissue factor (TF), tissue factor pathway inhibitor (TFPI), Factor VII (FVII:C), Factor VIII (FVIII:C), prothrombin, fibrinogen, and antithrombin III.

Main Results:

  • Elevated TF and TFPI in AMI; increased TF but decreased TFPI in AIS.
  • Higher FVII:C in AIS, higher FVIII:C in AMI.
  • Increased prothrombin and fibrinogen, with decreased antithrombin III in both AMI and AIS groups.
  • Distinct coagulation factor changes observed between AMI and AIS.

Conclusions:

  • The initiation of the tissue factor (TF) pathway is associated with thrombotic events in AMI and AIS, indicating a hypercoagulable state.
  • Coagulation factor profiles differ significantly between AMI and AIS, suggesting distinct pathophysiological mechanisms.
  • Further research into these specific factor alterations may lead to targeted therapies.

Related Concept Videos

Extrinsic and Intrinsic Pathways of Hemostasis01:20

Extrinsic and Intrinsic Pathways of Hemostasis

Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Coagulation01:09

Coagulation

The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...